$334.75 0%
SWAV Stock Price vs. AI Score
Data gathered: February 1

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - ShockWave Medical (SWAV)

Analysis generated December 26, 2024. Powered by Chat GPT.

ShockWave Medical is a medical device company that specializes in the development of intravascular lithotripsy (IVL) systems for the treatment of calcified cardiovascular disease. The company’s innovative technology is designed to improve patient outcomes by using sonic pressure waves to fracture calcium deposits in arteries, making it easier for stents to effectively expand and reduce blockages. ShockWave Medical has been increasingly recognized for its groundbreaking solutions in the healthcare sector, leading to a strong position in its niche market.

Read full AI stock Analysis

Stock Alerts - ShockWave Medical (SWAV)

company logo ShockWave Medical | December 31
Business Outlook among employees is up by 4.8% over the last month.
company logo ShockWave Medical | December 24
Employee Rating is up by 2.6% over the last month.
company logo ShockWave Medical | December 10
Web Traffic is down by 65.3% over the last month.
company logo ShockWave Medical | November 26
Job postings are down by 27.1% in the last couple of days.

About ShockWave Medical

ShockWave Medical, Inc., a medical device company, develops intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and internationally.


ShockWave Medical
Price $334.75
Target Price Sign up
Volume 4,710,000
Market Cap $12.6B
Year Range $334.15 - $334.83
Dividend Yield 0%
PE Ratio 78.76
Analyst Rating 20% buy
Industry Medical Devices

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24216M135M191M55M56M1.440
Q4 '23198M118M178M44M59M1.160
Q3 '23184M103M162M35M51M0.920
Q2 '23179M111M156M29M36M0.760
Q1 '23160M96M140M39M43M1.030

Insider Transactions View All

Zacharias Isaac filed to sell 56,818 shares at $287.7.
March 27 '24
FRANCIS LAURA filed to sell 3,551 shares at $300.
March 27 '24
Phung Trinh filed to sell 31,024 shares at $253.1.
March 6 '24
WATKINS FRANK T filed to sell 4,532 shares at $254.6.
March 7 '24
WATKINS FRANK T filed to sell 5,232 shares at $253.2.
March 7 '24

What is the Market Cap of ShockWave Medical?

The Market Cap of ShockWave Medical is $12.6B.

What is ShockWave Medical's PE Ratio?

As of today, ShockWave Medical's PE (Price to Earnings) ratio is 78.76.

What is the current stock price of ShockWave Medical?

Currently, the price of one share of ShockWave Medical stock is $334.75.

How can I analyze the SWAV stock price chart for investment decisions?

The SWAV stock price chart above provides a comprehensive visual representation of ShockWave Medical's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ShockWave Medical shares. Our platform offers an up-to-date SWAV stock price chart, along with technical data analysis and alternative data insights.

Does SWAV offer dividends to its shareholders?

As of our latest update, ShockWave Medical (SWAV) does not offer dividends to its shareholders. Investors interested in ShockWave Medical should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of ShockWave Medical?

Some of the similar stocks of ShockWave Medical are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.